NCT00603057View on ClinicalTrials.gov

Using Imaging and Molecular Markers to Predict Tumor Response and Lung Toxicity in Lung Cancer

CompletedOBSERVATIONAL
Enrollment

115

Participants

Timeline

Start Date

May 31, 2007

Primary Completion Date

September 30, 2013

Study Completion Date

March 31, 2015

Conditions
Non-Small Cell Lung Cancer
Trial Locations (1)

48109

University of Michigan, Ann Arbor

All Listed Sponsors
lead

University of Michigan Rogel Cancer Center

OTHER

NCT00603057 - Using Imaging and Molecular Markers to Predict Tumor Response and Lung Toxicity in Lung Cancer | Biotech Hunter | Biotech Hunter